These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26775802)

  • 1. Cardiovascular symptoms in patients with systemic mast cell activation disease.
    Kolck UW; Haenisch B; Molderings GJ
    Transl Res; 2016 Aug; 174():23-32.e1. PubMed ID: 26775802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases.
    Afrin LB; Pöhlau D; Raithel M; Haenisch B; Dumoulin FL; Homann J; Mauer UM; Harzer S; Molderings GJ
    Brain Behav Immun; 2015 Nov; 50():314-321. PubMed ID: 26162709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options.
    Afrin LB; Butterfield JH; Raithel M; Molderings GJ
    Ann Med; 2016; 48(3):190-201. PubMed ID: 27012973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast Cell Disorders In Drug Hypersensitivity.
    Bonadonna P; Bonifacio M; Zanotti R
    Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Practical Guide for Treatment of Pain in Patients with Systemic Mast Cell Activation Disease.
    Wirz S; Molderings GJ
    Pain Physician; 2017 Sep; 20(6):E849-E861. PubMed ID: 28934791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding.
    Afrin LB; Dempsey TT; Rosenthal LS; Dorff SR
    J Obstet Gynaecol; 2019 Jul; 39(5):664-669. PubMed ID: 30964355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast Cell Activation Disease and Microbiotic Interactions.
    Afrin LB; Khoruts A
    Clin Ther; 2015 May; 37(5):941-53. PubMed ID: 25773459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current options in the treatment of mast cell mediator-related symptoms in mastocytosis.
    Escribano L; Akin C; Castells M; Schwartz LB
    Inflamm Allergy Drug Targets; 2006 Jan; 5(1):61-77. PubMed ID: 16613565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of mast cell activation syndrome with sunitinib.
    Afrin LB; Cichocki FM; Patel K; Molderings GJ
    Eur J Haematol; 2015 Dec; 95(6):595-7. PubMed ID: 26072665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment options for mast cell activation disease.
    Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation.
    Parente R; Giudice V; Cardamone C; Serio B; Selleri C; Triggiani M
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
    González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
    Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells and mastocytosis.
    Söderholm JD
    Dig Dis; 2009; 27 Suppl 1():129-36. PubMed ID: 20203509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastocytosis - an update.
    Amon U; Hartmann K; Horny HP; Nowak A
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell mediators in allergic inflammation and mastocytosis.
    Castells M
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):465-85. PubMed ID: 16931289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
    Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
    Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastocytosis: mediator-related signs and symptoms.
    Castells M; Austen KF
    Int Arch Allergy Immunol; 2002 Feb; 127(2):147-52. PubMed ID: 11919427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.